Correction: Immune cell senescence and chronic bone diseases: osteoimmune mechanisms and therapeutic perspectives - Top-Institutions - MDSpire

Correction: Immune cell senescence and chronic bone diseases: osteoimmune mechanisms and therapeutic perspectives

  • By

  • Zhi Wen

  • Min Yu

  • Siren Li

  • Fan Zeng

  • Jing Li

  • Jiabin Li

  • Guiping Liang

  • Kang Wang

  • June 19, 2026

  • 0 min

Share

Top Institutions in Orthopedic Medicine

Brief introduction explaining scope and methodology.

  • #1

    Hunan University of Medicine General Hospital
    Hunan University of Medicine General Hospital

    Hunan, China

    Key Differentiators

    • Rheumatology

  • #2

    Administration of Traditional Chinese Medicine of Jiangxi Province
    Administration of Traditional Chinese Medicine of Jiangxi Province

    Nanchang, China

    Key Differentiators

    • Rheumatology

  • #3

    Jiangxi Provincial Natural Science Foundation
    Jiangxi Provincial Natural Science Foundation

    Nanchang, China

    Key Differentiators

    • Rheumatology

  • #4

    Hunan Provincial Natural Science Foundation
    Hunan Provincial Natural Science Foundation

    Hunan, China

    Key Differentiators

    • Rheumatology

Original Source(s)

Correction: Immune cell senescence and chronic bone diseases: osteoimmune mechanisms and therapeutic perspectives

  • by Zhi Wen, Min Yu, Siren Li, Fan Zeng, Jing Li, Jiabin Li, Guiping Liang, Kang Wang

  • June 19, 2026

Related Content

BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Surgical management of tumor-mimicking posteriorly migrated lumbar disc fragment using a quadrant minimally invasive approach: a case report and literature review